These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12595593)

  • 1. Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse.
    Dombrowsky H; Clark GT; Rau GA; Bernhard W; Postle AD
    Pediatr Res; 2003 Mar; 53(3):447-54. PubMed ID: 12595593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual cftr expression varies with age in cftr(tm1Hgu) cystic fibrosis mice: impact on morphology and physiology.
    Larbig M; Jansen S; Dorsch M; Bernhard W; Bellmann B; Dorin JR; Porteous DJ; Von Der Hardt H; Steinmetz I; Hedrich HJ; Tuemmler B; Tschernig T
    Pathobiology; 2002-2003; 70(2):89-97. PubMed ID: 12476034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of surfactant phosphatidylcholine molecular species in cftr(tm1HGU/tm1HGU) mice compared to MF-1 mice.
    Bernhard W; Bertling A; Dombrowsky H; Vieten G; Rau G; von der Hardt H; Freihorst J
    Exp Lung Res; 2001 Jun; 27(4):349-66. PubMed ID: 11400861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
    Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
    Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
    Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load.
    Davidson DJ; Webb S; Teague P; Govan JR; Dorin JR
    Pathobiology; 2004; 71(3):152-8. PubMed ID: 15051928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells.
    Bhura-Bandali FN; Suh M; Man SF; Clandinin MT
    J Nutr; 2000 Dec; 130(12):2870-5. PubMed ID: 11110839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr-/- knockout mice.
    Ollero M; Laposata M; Zaman MM; Blanco PG; Andersson C; Zeind J; Urman Y; Kent G; Alvarez JG; Freedman SD
    Metabolism; 2006 Sep; 55(9):1192-200. PubMed ID: 16919538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.
    Jouret F; Bernard A; Hermans C; Dom G; Terryn S; Leal T; Lebecque P; Cassiman JJ; Scholte BJ; de Jonge HR; Courtoy PJ; Devuyst O
    J Am Soc Nephrol; 2007 Mar; 18(3):707-18. PubMed ID: 17287432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
    Salvatore F; Scudiero O; Castaldo G
    Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
    Beharry S; Ackerley C; Corey M; Kent G; Heng YM; Christensen H; Luk C; Yantiss RK; Nasser IA; Zaman M; Freedman SD; Durie PR
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal potential difference and the functional expression of CFTR in the gastrointestinal epithelia in cystic fibrosis mouse models.
    Weiner SA; Caputo C; Bruscia E; Ferreira EC; Price JE; Krause DS; Egan ME
    Pediatr Res; 2008 Jan; 63(1):73-8. PubMed ID: 18043508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues.
    Hardcastle J; Harwood MD; Taylor CJ
    J Pharm Pharmacol; 2004 Mar; 56(3):329-38. PubMed ID: 15025858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.
    Stalvey MS; Brusko TM; Mueller C; Wasserfall CH; Schatz DA; Atkinson MA; Flotte TR
    Cytokine; 2008 Oct; 44(1):154-9. PubMed ID: 18778952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
    French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
    J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of cAMP- and calcium-mediated amylase secretion in isolated pancreatic acini from cystic fibrosis mice.
    Tang S; Beharry S; Kent G; Durie PR
    Pediatr Res; 1999 Apr; 45(4 Pt 1):482-8. PubMed ID: 10203138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.